• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>India Fund

India Fund

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Enanta Announces SVR12 results of 95% from AbbVie’s GIFT-1 Study in Non-cirrhotic, Japanese Patients with Genotype 1b Hepatitis C Virus1

    Enanta Announces SVR12 results of 95% from AbbVie’s GIFT-1 Study in Non-cirrhotic, Japanese Patients with Genotype 1b Hepatitis C Virus1

  2. Celsion Corporation Announces ASCO 2015 GEN-1 Immunotherapy Phase 1b Results in Ovarian Cancer Presentation

    Celsion Corporation Announces ASCO 2015 GEN-1 Immunotherapy Phase 1b Results in Ovarian Cancer Presentation

  3. Where Are the Opportunities in Emerging Markets Today?

    We take a closer look at India, Taiwan, and Malaysia.

  4. Commodities CEFs Tank in September

    The Bond King's departure had a small impact on CEF performance compared with the onslaught in the commodities market.

  5. Optimism in India

    Appears to be priced in, for now.

  6. 2011 Closed-End Funds Year in Review

    Despite the market's wild ride, most CEFs closed the year with positive share price and NAV returns. 

  7. What the Big Guys Are Buying (and Selling)

    A look at ownership data can provide a more detailed look at what mutual funds and institutional players are buying and selling. 

  8. For Closed-End Funds, Cheaper Isn't Necessarily Better

    When it comes to expenses, CEFs are quite different than open-end mutual funds.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.